Heron Therapeutics (HRTX) Other Non Operating Income (2014 - 2026)
Heron Therapeutics (HRTX) reported Other Non Operating Income of -$3.3 million for Q1 2026, down 544.7% on a YoY basis from $752415.1 in Q1 2025, and up 58.24% quarter-over-quarter from -$8.0 million in Q4 2025.
Heron Therapeutics (HRTX) Other Non Operating Income (2014 - 2026) Analysis & Trends
Heron Therapeutics has reported Other Non Operating Income for 13 years, with the latest figure at -$3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 544.7% year-over-year to -$3.3 million; the trailing twelve-month figure through Mar 2026 stood at -$17.6 million (down 919.28% YoY), and the FY2025 full-year result was -$11.3 million, down 2736.98% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$3.3 million, up from -$8.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was $2.0 million in Q4 2024, with the low at -$8.0 million in Q4 2025.
- Historically, Other Non Operating Income has averaged -$1.5 million across 5 years, with a median of -$454500.0 in 2024.
- Annual changes were most pronounced in 2024 — Other Non Operating Income jumped 455.25% — and 2025, when it sank 1310.26%.
- Heron Therapeutics' Other Non Operating Income stood at $1.3 million in 2022, then plunged by 105.98% to -$79000.0 in 2023, then surged by 2596.2% to $2.0 million in 2024, then tumbled by 506.34% to -$8.0 million in 2025, then soared by 58.24% to -$3.3 million in 2026.
- The last three Other Non Operating Income figures came in at -$3.3 million (Q1 2026), -$8.0 million (Q4 2025), and -$5.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.35 Mn |
| Dec 31, 2025 | -8.01 Mn |
| Sep 30, 2025 | -5.50 Mn |
| Jun 30, 2025 | -744,000.00 |
| Mar 31, 2025 | -519,000.00 |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | -390,000.00 |
| Jun 30, 2024 | -2.79 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Sep 30, 2023 | -79,000.00 |
| Jun 30, 2023 | 344,000.00 |
| Mar 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | -26,000.00 |
| Jun 30, 2022 | -6.86 Mn |
| Mar 31, 2022 | -965,000.00 |
| Dec 31, 2021 | 868,000.00 |
| Sep 30, 2021 | -700,000.00 |
| Jun 30, 2021 | -546,000.00 |
| Mar 31, 2021 | -500,000.00 |